Supernus Pharmaceuticals/ US8684591089 /

7/1/2022 9:59:53 PM	Chg. +0.42	Volume	Bid-	Ask-	High	Low
29.35USD	+1.45%	18,359 Turnover: 534,093.51	-Bid Size: -	-Ask Size: -	29.43	28.44

GlobeNewswire 3/17 Supernus Notifies Nasdaq Regarding Non-Compliance with Listing Requirement and Expectation to Regain...

GlobeNewswire 3/7 Freshworks Enables Supernus Pharmaceuticals to Scale Operational Excellence and Get Critical Medicat...

GlobeNewswire 3/2 Supernus to Participate in Annual Cowen Health Care Conference

GlobeNewswire 2/28 Supernus Announces Preliminary Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 2/22 Supernus to Provide Preliminary Fourth Quarter and Full Year 2021 Financial Results and Host Confere...

GlobeNewswire 2/22 Supernus Receives Notice Assigning Early October 2022 PDUFA for SPN-830 Apomorphine Infusion Device ...

GlobeNewswire 12/8/2021 Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

GlobeNewswire 11/25/2021 Supernus Pharmaceuticals Targeted in Ransomware Incident

GlobeNewswire 11/24/2021 Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals

GlobeNewswire 11/23/2021 Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmac...

GlobeNewswire 11/18/2021 Supernus to Participate in Annual Piper Sandler Healthcare Conference

GlobeNewswire 11/10/2021 Supernus to Participate in Upcoming November Investor Conferences

GlobeNewswire 11/3/2021 Supernus Announces Third Quarter 2021 Financial Results

GlobeNewswire 10/28/2021 Moore Kuehn Encourages PSXP, BRPM, HFC, and ADMS Investors to Contact Law Firm

GlobeNewswire 10/27/2021 Supernus to Announce Third Quarter 2021 Financial Results and Host Conference Call on November 3, 20...

GlobeNewswire 10/27/2021 ADAMAS ALERT: Bragar Eagel & Squire, P.C. Announces Commencement of Tender Offer and Encourages Inve...

GlobeNewswire 10/21/2021 Lifshitz Law Firm, P.C. Announces Investigation of ADMS, ACBI, FLXN, and HBMD

GlobeNewswire 10/20/2021 Holly Robinson Peete Partners with Supernus to Raise Awareness During ADHD Awareness Month

GlobeNewswire 10/18/2021 SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, AZPN, GSKY, GWB; Shareholders are Enc...

GlobeNewswire 10/14/2021 ADAMAS ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of ADMS and Encourages Investors to Cont...

GlobeNewswire 10/12/2021 SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ADMS, FLXN, AZPN, CXP; Shareholders are Enc...

GlobeNewswire 10/12/2021 SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Adamas Pharmaceuticals, Inc. Merge...

GlobeNewswire 10/11/2021 Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio

GlobeNewswire 9/3/2021 Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA

GlobeNewswire 9/2/2021 Supernus to Participate in Upcoming September Investor Conferences